QA: Nanoviricides INC in us_pharma/2013

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001379006_2014_Nanoviricides_INC.pdf

Logs

warning The EntityCommonStockSharesOutstanding does not exist industry.us_generic {}
warning Missing logo subcommand.report {}

Graph

Absolute values for 0001379006, Nanoviricides INC

  xvar xval
0 AssetsCurrent 14,521,625
1 IntangibleAssetsNetIncludingGoodwill 417,033
2 PropertyPlantAndEquipmentNet 468,896
3 remainder_Assets 1,000,000
4 LiabilitiesCurrent 1,178,184
5 LiabilitiesNoncurrent 7,219,718
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 2,297,470
9 ResearchAndDevelopmentExpense 4,292,909
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome -2,285,289
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 16,407,554
1 Liabilities 8,397,902
2 Expenses 6,590,379
3 Revenues 0
4 StockholdersEquity 8,009,652
5 NetIncome -8,875,668
6 ComprehensiveNetIncome -8,875,668
7 BaseVar 16,840,562
8 EconomicCapitalRatiobeforeLimitedLiability 0.692
9 EconomicCapitalRatio 2.05

Edgar->Model Mapping

Feature Distribution

Change over Time